PINK Archives - BioTuesdays

Feature

Perimeter’s positive topline results signal potential for wide-spread user adoption of next-gen, ultra-high-res, AI-driven imaging tool during breast cancer surgeries

Perimeter Medical Imaging AI (TSX-V:PINK; OTC:PYNKF) is poised to transform cancer surgery, as positive topline results from a pivotal study designed to support the company’s planned FDA premarket approval (PMA)...

December 3, 2024

Developments

Perimeter’s B-Series OCT with ImgAssist AI demonstrates super-superiority compared to standard-of-care in breast cancer surgery pivotal clinical trial

Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) announced positive topline results from the pivotal study designed to support its planned FDA PMA submission for approval to market its next-generation Perimeter B...

November 20, 2024

Developments

Perimeter completes patient enrollment for pivotal trial evaluating next-gen OCT B-Series with ImgAssist AI in breast cancer surgery

Perimeter Medical Imaging AI (TSXV:PINK; OTC:PYNKF) has announced the completion of patient enrollment in a pivotal clinical study evaluating its next-generation Perimeter B-Series OCT system, which combines proprietary...

October 3, 2024

Developments

Perimeter reports progress on several fronts

Perimeter Medical Imaging AI (TSX:PINK; OTC:PYNKF; FSE:4PC) highlighted several positive developments and achievements in its Q2 report and conference call yesterday. Perimeter is a medical technology company working to...

August 15, 2024

Feature

Perimeter aims to transform cancer surgery with ultra-high-res imaging tools

Perimeter Medical Imaging AI (TSX:PINK; OTC:PYNKF; FSE:4PC) is developing breakthrough ultra-high-resolution, real-time, advanced imaging tools to assist cancer surgeons in achieving clean margins during initial surgery.

July 2, 2024

Executive Moves

Perimeter Medical names Adrian Mendes as CEO; appoints Dr. Josh Vose to board

The board of Perimeter Medical Imaging AI (TSXV:PINK; OTC:PYNKF; FSE:4PC) appointed Adrian Mendes as CEO, effective immediately, succeeding Jeremy Sobotta, who has resigned for personal reasons, effective June 15, 2023...

June 5, 2023

Markets

Research Capital starts Perimeter Medical Imaging at speculative buy; PT $4.90 (Canadian)

Research Capital initiated coverage of Perimeter Medical Imaging (TSXV:PINK) with a “speculative buy” rating and a 12-month price target of $4.90 (Canadian). The stock closed at $3.37 on June 28. Perimeter is a medical...

June 29, 2021

Markets

Raymond James ups Perimeter Medical Imaging PT to $6.50 (Canadian) from $3

Raymond James raised its price target for Perimeter Medical Imaging (TSXV:PINK) to $6.50 (Canadian) from $3, citing a deeper look at the artificial intelligence-enabled application of the company’s Optical...

April 5, 2021

Markets

Leede Jones Gable starts Perimeter Medical Imaging at speculative buy; PT $6.75 (Canadian)

Leede Jones Gable initiated coverage of Perimeter Medical Imaging (TSXV:PINK) with a “speculative buy” rating and price target of $6.75 (Canadian). The stock closed at $4.30 on March 26. The firm’s lead medical device...

March 29, 2021

Markets

Raymond James starts Perimeter Medical Imaging at OP; PT $3 (Canadian)

Raymond James initiated coverage of Perimeter Medical Imaging AI (TSXV:PINK) with an “outperform” rating and price target of $3 (Canadian). The stock closed at $2.19 on Nov. 6. Perimeter is commercializing its Optical...

November 9, 2020

Tag - PINK

Perimeter’s positive topline results signal potential for wide-spread user adoption of next-gen, ultra-high-res, AI-driven imaging tool during breast cancer surgeries

Perimeter’s B-Series OCT with ImgAssist AI demonstrates super-superiority compared to standard-of-care in breast cancer surgery pivotal clinical trial

Perimeter completes patient enrollment for pivotal trial evaluating next-gen OCT B-Series with ImgAssist AI in breast cancer surgery

Perimeter reports progress on several fronts

Perimeter aims to transform cancer surgery with ultra-high-res imaging tools

Perimeter Medical names Adrian Mendes as CEO; appoints Dr. Josh Vose to board

Research Capital starts Perimeter Medical Imaging at speculative buy; PT $4.90 (Canadian)

Raymond James ups Perimeter Medical Imaging PT to $6.50 (Canadian) from $3

Leede Jones Gable starts Perimeter Medical Imaging at speculative buy; PT $6.75 (Canadian)

Raymond James starts Perimeter Medical Imaging at OP; PT $3 (Canadian)

General

More